| Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer NMA Wright, GD Goss Translational Lung Cancer Research 8 (Suppl 3), S247, 2019 | 69 | 2019 |
| β1 integrin is required for anchorage-independent growth and invasion of tumor cells in a context dependent manner AM Schooley, NM Andrews, H Zhao, CL Addison Cancer letters 316 (2), 157-167, 2012 | 31 | 2012 |
| Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first‐line platinum chemotherapy in high grade serous ovarian cancer JI Weberpals, TJ Pugh, P Marco‐Casanova, GD Goss, N Andrews Wright, ... Cancer Medicine 10 (9), 3045-3058, 2021 | 12 | 2021 |
| A dose-finding study of the SMAC mimetic Debio 1143 when given in combination with avelumab to patients with advanced solid malignancies RA Juergens, QS Chu, DJ Renouf, SA Laurie, D Purcea, E McWhirter, ... Journal of Clinical Oncology 37 (15_ suppl), 2599-2599, 2019 | 4 | 2019 |
| Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian Arctic GD Goss, JN Spaans, D Huntsman, T Asmis, NM Andrews Wright, ... Current Oncology 29 (5), 3171-3186, 2022 | 3 | 2022 |
| Tumor molecular profiling to differentiate extreme responses to first-line platinum-based chemotherapy in suboptimally debulked serous ovarian cancer patients. JI Weberpals, T Pugh, GD Goss, B Lo, N Andrews Wright, L Bernard, ... Journal of Clinical Oncology 36 (15_suppl), 5561-5561, 2018 | 2 | 2018 |
| Outcomes of recurrent and metastatic endometrial cancer (RMEC) treated with systemic progestins. A Kulkarni, N Andrews Wright, AN Forget, R Mallick, TO Ramsay, ... Journal of Clinical Oncology 40 (16_suppl), 5585-5585, 2022 | 1 | 2022 |
| Recurrent vulvar squamous cell carcinoma: An analysis of clinical outcomes by treatment modality including surgery, chemotherapy, and radiation. T Dinh, N Andrews Wright, H Iyer, JI Weberpals Journal of Clinical Oncology 38 (15_suppl), e18033-e18033, 2020 | | 2020 |
